Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action

Cell Metabolism

Volumn 12, Issue 3, 2010, Pages 237-249

  Wunderlich, F Thomas ^a   Ströhle, Peter ^a   Könner, A Christine ^a   Gruber, Sabine ^a   Tovar, Sulay ^a   Brönneke, Hella S ^b   Juntti Berggren, Lisa ^c   Li, Luo Sheng ^c   Van Rooijen, Nico ^d   Libert, Claude ^e   Berggren, Per Olof ^c   Brüning, Jens C ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE; GLYCOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME PHOSPHORYLATION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLYCOGEN SYNTHESIS; HEPATITIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER CELL; LIVER PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; ANIMAL; BIOSYNTHESIS; CYTOLOGY; ENERGY METABOLISM; GENETICS; HOMEOSTASIS; HUMAN; INFLAMMATION; KNOCKOUT MOUSE; KUPFFER CELL; LIVER; METABOLISM; OBESITY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADIPOSITY; ANIMALS; ENERGY METABOLISM; GLUCOSE; GLYCOGEN; HOMEOSTASIS; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-10; INTERLEUKIN-6; KUPFFER CELLS; LIVER; MICE; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956335194     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2010.06.011     Document Type: Article

References (47)

1. V. Aguirre, T. Uchida, L. Yenush, R. Davis, and M.F. White The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307) J. Biol. Chem. 275 2000 9047 9054
2. M.C. Arkan, A.L. Hevener, F.R. Greten, S. Maeda, Z.W. Li, J.M. Long, A. Wynshaw-Boris, G. Poli, J. Olefsky, and M. Karin IKK-beta links inflammation to obesity-induced insulin resistance Nat. Med. 11 2005 191 198
3. J.P. Bastard, C. Jardel, E. Bruckert, P. Blondy, J. Capeau, M. Laville, H. Vidal, and B. Hainque Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss J. Clin. Endocrinol. Metab. 85 2000 3338 3342
4. D. Cai, M. Yuan, D.F. Frantz, P.A. Melendez, L. Hansen, J. Lee, and S.E. Shoelson Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat. Med. 11 2005 183 190
5. A.L. Carey, G.R. Steinberg, S.L. Macaulay, W.G. Thomas, A.G. Holmes, G. Ramm, O. Prelovsek, C. Hohnen-Behrens, M.J. Watt, and D.E. James Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase Diabetes 55 2006 2688 2697
6. D. Chida, T. Osaka, O. Hashimoto, and Y. Iwakura Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice Diabetes 55 2006 971 977
7. E.H. Choy, D.A. Isenberg, T. Garrood, S. Farrow, Y. Ioannou, H. Bird, N. Cheung, B. Williams, B. Hazleman, and R. Price Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial Arthritis Rheum. 46 2002 3143 3150
8. L. Dejager, and C. Libert Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice Cytokine 42 2008 55 61
9. G.B. Di Gregorio, L. Hensley, T. Lu, G. Ranganathan, and P.A. Kern Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity Am. J. Physiol. Endocrinol. Metab. 287 2004 E182 E187
10. P. Ferré, A. Leturque, A.F. Burnol, L. Penicaud, and J. Girard A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat Biochem. J. 228 1985 103 110
11. S.J. Fisher, and C.R. Kahn Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production J. Clin. Invest. 111 2003 463 468
12. E. Gropp, M. Shanabrough, E. Borok, A.W. Xu, R. Janoschek, T. Buch, L. Plum, N. Balthasar, B. Hampel, and A. Waisman Agouti-related peptide-expressing neurons are mandatory for feeding Nat. Neurosci. 8 2005 1289 1291
13. P. Hänninen, A. Soini, N. Meltola, J. Soini, J. Soukka, and E. Soini A new microvolume technique for bioaffinity assays using two-photon excitation Nat. Biotechnol. 18 2000 548 550
14. J. Hirosumi, G. Tuncman, L. Chang, C.Z. Görgün, K.T. Uysal, K. Maeda, M. Karin, and G.S. Hotamisligil A central role for JNK in obesity and insulin resistance Nature 420 2002 333 336
15. A.G. Holmes, J.L. Mesa, B.A. Neill, J. Chung, A.L. Carey, G.R. Steinberg, B.E. Kemp, R.J. Southgate, G.I. Lancaster, and C.R. Bruce Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARalpha and UCP2 expression in rats J. Endocrinol. 198 2008 367 374
16. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91
17. G.S. Hotamisligil, A. Budavari, D. Murray, and B.M. Spiegelman Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha J. Clin. Invest. 94 1994 1543 1549
18. G.S. Hotamisligil, D.L. Murray, L.N. Choy, and B.M. Spiegelman Tumor necrosis factor alpha inhibits signaling from the insulin receptor Proc. Natl. Acad. Sci. USA 91 1994 4854 4858
19. G.S. Hotamisligil, P. Arner, R.L. Atkinson, and B.M. Spiegelman Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance Diabetes 46 1997 451 455
20. H. Inoue, W. Ogawa, A. Asakawa, Y. Okamoto, A. Nishizawa, M. Matsumoto, K. Teshigawara, Y. Matsuki, E. Watanabe, and R. Hiramatsu Role of hepatic STAT3 in brain-insulin action on hepatic glucose production Cell Metab. 3 2006 267 275
21. C. Kellendonk, C. Opherk, K. Anlag, G. Schütz, and F. Tronche Hepatocyte-specific expression of Cre recombinase Genesis 26 2000 151 153
22. H.J. Kim, T. Higashimori, S.Y. Park, H. Choi, J. Dong, Y.J. Kim, H.L. Noh, Y.R. Cho, G. Cline, Y.B. Kim, and J.K. Kim Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo Diabetes 53 2004 1060 1067
23. A. Kleinridders, D. Schenten, A.C. Konner, B.F. Belgardt, J. Mauer, T. Okamura, F.T. Wunderlich, R. Medzhitov, and J.C. Bruning MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance in diet-induced obesity Cell Metab. 10 2009 249 259
24. P.J. Klover, T.A. Zimmers, L.G. Koniaris, and R.A. Mooney Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice Diabetes 52 2003 2784 2789
25. A.C. Könner, R. Janoschek, L. Plum, S.D. Jordan, E. Rother, X. Ma, C. Xu, P. Enriori, B. Hampel, and G.S. Barsh Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production Cell Metab. 5 2007 438 449
26. A. Lernmark The preparation of, and studies on, free cell suspensions from mouse pancreatic islets Diabetologia 10 1974 431 438
27. A. Mackiewicz, M. Wiznerowicz, E. Roeb, A. Karczewska, J. Nowak, P.C. Heinrich, and S. Rose-John Soluble interleukin 6 receptor is biologically active in vivo Cytokine 7 1995 142 149
28. N. Nishimoto, K. Yoshizaki, N. Miyasaka, K. Yamamoto, S. Kawai, T. Takeuchi, J. Hashimoto, J. Azuma, and T. Kishimoto Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial Arthritis Rheum. 50 2004 1761 1769
29. S. Nishimura, I. Manabe, M. Nagasaki, K. Eto, H. Yamashita, M. Ohsugi, M. Otsu, K. Hara, K. Ueki, and S. Sugiura CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity Nat. Med. 15 2009 914 920
30. M. Olszanecka-Glinianowicz, B. Zahorska-Markiewicz, J. Janowska, and A. Zurakowski Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity Metabolism 53 2004 1268 1273
31. B.K. Pedersen, and M.A. Febbraio Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis J. Appl. Physiol. 102 2007 814 816
32. B.K. Pedersen, A. Steensberg, C. Fischer, C. Keller, P. Keller, P. Plomgaard, E. Wolsk-Petersen, and M. Febbraio The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? Proc. Nutr. Soc. 63 2004 263 267
33. M. Penkowa, C. Keller, P. Keller, S. Jauffred, and B.K. Pedersen Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise FASEB J. 17 2003 2166 2168
34. P. Plomgaard, K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J.R. Zierath, and B.K. Pedersen Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation Diabetes 54 2005 2939 2945
35. L. Plum, B.F. Belgardt, and J.C. Brüning Central insulin action in energy and glucose homeostasis J. Clin. Invest. 116 2006 1761 1766
36. C.I. Rodríguez, F. Buchholz, J. Galloway, R. Sequerra, J. Kasper, R. Ayala, A.F. Stewart, and S.M. Dymecki High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP Nat. Genet. 25 2000 139 140
37. G. Sabio, M. Das, A. Mora, Z. Zhang, J.Y. Jun, H.J. Ko, T. Barrett, J.K. Kim, and R.J. Davis A stress signaling pathway in adipose tissue regulates hepatic insulin resistance Science 322 2008 1539 1543
38. M. Sadagurski, L. Norquay, J. Farhang, K. D'Aquino, K. Copps, and M.F. White Human IL6 enhances leptin action in mice Diabetologia 53 2010 525 535
39. C. Southern, D. Schulster, and I.C. Green Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism FEBS Lett. 276 1990 42 44
40. K. Ueki, T. Kondo, and C.R. Kahn Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms Mol. Cell. Biol. 24 2004 5434 5446
41. N. Van Rooijen, and A. Sanders Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid Hepatology 23 1996 1239 1243
42. V. Wallenius, K. Wallenius, B. Ahrén, M. Rudling, H. Carlsten, S.L. Dickson, C. Ohlsson, and J.O. Jansson Interleukin-6-deficient mice develop mature-onset obesity Nat. Med. 8 2002 75 79
43. Z. Xing, J. Gauldie, G. Cox, H. Baumann, M. Jordana, X.F. Lei, and M.K. Achong IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses J. Clin. Invest. 101 1998 311 320
44. H. Xu, G.T. Barnes, Q. Yang, G. Tan, D. Yang, C.J. Chou, J. Sole, A. Nichols, J.S. Ross, L.A. Tartaglia, and H. Chen Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J. Clin. Invest. 112 2003 1821 1830
45. D.Y. Yuen, R.M. Dwyer, V.B. Matthews, L. Zhang, B.G. Drew, B. Neill, B.A. Kingwell, M.G. Clark, S. Rattigan, and M.A. Febbraio Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expression Diabetes 58 2009 1086 1095
46. S. Zhang, and K.H. Kim TNF-alpha inhibits glucose-induced insulin secretion in a pancreatic beta-cell line (INS-1) FEBS Lett. 377 1995 237 239
47. X. Zhang, G. Zhang, H. Zhang, M. Karin, H. Bai, and D. Cai Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity Cell 135 2008 61 73